Nephrotic Syndrome Pathophysiology

The nephrotic syndrome is the clinical consequence of a glomerular filtration barrier that has become abnormally permeable to plasma protein. Its defining feature is heavy proteinuria, classically accompanied by hypoalbuminaemia, oedema, and hyperlipidaemia. This entry focuses on the pathophysiology — how injury to the podocyte and the slit diaphragm produces protein loss and the downstream disturbances — rather than on the clinical management of specific diseases.

Definition

Nephrotic syndrome is a clinical state defined by heavy glomerular proteinuria with hypoalbuminaemia and oedema (commonly with hyperlipidaemia), resulting from increased permeability of the glomerular filtration barrier, chiefly through injury to the podocyte and its slit diaphragm.

Scope

The entry explains the structure of the filtration barrier, the central role of the podocyte and slit diaphragm in restricting protein passage, and the mechanisms linking heavy proteinuria to hypoalbuminaemia, oedema, hyperlipidaemia, and hypercoagulability. It uses minimal change disease, focal segmental glomerulosclerosis, and membranous nephropathy as illustrative lesions. It is a reference description of mechanism, not treatment guidance.

Core questions

• How does the normal filtration barrier restrict the passage of albumin and larger proteins?
• What podocyte and slit-diaphragm changes increase protein permeability?
• How does heavy proteinuria lead to hypoalbuminaemia, oedema, and hyperlipidaemia?
• Which mechanisms underlie the increased thrombotic risk seen in the nephrotic state?

Key concepts

• Glomerular filtration barrier (endothelium, basement membrane, podocyte)
• Podocyte and slit diaphragm
• Foot-process effacement
• Selective versus non-selective proteinuria
• Hypoalbuminaemia and oedema
• Hyperlipidaemia
• Hypercoagulability
• Target antigens (e.g. PLA2R in membranous nephropathy)

Mechanisms

The glomerular filtration barrier comprises the fenestrated endothelium, the glomerular basement membrane, and the podocyte with its interdigitating foot processes bridged by the slit diaphragm; together these restrict the passage of albumin and larger plasma proteins. Nephrotic-range proteinuria reflects loss of this size- and charge-selective restriction, most often through podocyte injury with effacement of foot processes. In minimal change disease the podocyte is injured with little structural deposit; in focal segmental glomerulosclerosis podocyte depletion and scarring develop; in membranous nephropathy subepithelial immune deposits — in many cases directed against the podocyte antigen phospholipase A2 receptor (PLA2R) — disrupt the barrier. The resulting urinary protein loss lowers plasma albumin, contributing to oedema, while compensatory hepatic lipoprotein synthesis and altered clearance produce hyperlipidaemia, and urinary loss of regulatory proteins contributes to a hypercoagulable state (Benzing 2021; D'Agati 2011; Beck 2009; Fogo 2015).

Clinical relevance

Understanding the pathophysiology clarifies why the nephrotic syndrome links a single barrier defect to a recognisable cluster of findings and complications, and why certain lesions are characterised by molecular targets such as PLA2R. This entry describes mechanism for reference purposes; it does not define diagnostic thresholds or recommend treatment, which are matters for current guidelines and treating clinicians.

Epidemiology

Among adults, membranous nephropathy and focal segmental glomerulosclerosis are leading causes of the nephrotic syndrome, while minimal change disease is the predominant cause in children. The relative frequency varies with age, ethnicity, and biopsy practice, and the discovery of PLA2R as a target antigen has refined the classification of membranous nephropathy (D'Agati 2011; Beck 2009; Rovin 2021).

History

The nephrotic syndrome was long defined clinically and by light microscopy, but electron microscopy revealed foot-process effacement as a shared feature of podocyte injury, and immunofluorescence distinguished membranous and other patterns. The 2009 identification of the phospholipase A2 receptor as a target antigen in idiopathic membranous nephropathy marked a shift toward an antigen-based, mechanistic classification of one of its major causes (Beck 2009; Benzing 2021).

Key figures

• Thomas Benzing
• David J. Salant
• Laurence H. Beck
• Vivette D. D'Agati
• Agnes B. Fogo

Seminal works

• beck2009
• benzing2021
• dagati2011

Frequently asked questions

Why does heavy proteinuria cause oedema?

Urinary loss of albumin lowers plasma oncotic pressure and, together with renal sodium retention, favours movement and accumulation of fluid in the interstitium. This entry describes the mechanism rather than how oedema is managed.

What is the significance of the PLA2R antigen?

Phospholipase A2 receptor is a podocyte antigen targeted by autoantibodies in many cases of primary membranous nephropathy; its identification reframed that disease as an antigen-specific autoimmune podocytopathy and is used as a reference marker in classification.